Literature DB >> 25119961

Corneal graft rejection 10 years after penetrating keratoplasty in the cornea donor study.

Steven P Dunn1, Robin L Gal, Craig Kollman, Dan Raghinaru, Mariya Dontchev, Christopher L Blanton, Edward J Holland, Jonathan H Lass, Kenneth R Kenyon, Mark J Mannis, Shahzad I Mian, Christopher J Rapuano, Walter J Stark, Roy W Beck.   

Abstract

PURPOSE: The aim of this study was to assess the effect of donor and recipient factors on corneal allograft rejection and evaluate whether a rejection event was associated with graft failure.
METHODS: One thousand ninety subjects undergoing penetrating keratoplasty for a moderate risk condition (principally Fuchs dystrophy or pseudophakic corneal edema) were followed for up to 12 years. Associations of baseline recipient and donor factors with the occurrence of a rejection event were assessed in univariate and multivariate proportional hazards models.
RESULTS: Among 651 eyes with a surviving graft at 5 years, the 10-year graft failure (±99% confidence interval) rates were 12% ± 4% among eyes with no rejection events in the first 5 years, 17% ± 12% in eyes with at least 1 probable, but no definite rejection event, and 22% ± 20% in eyes with at least 1 definite rejection event. The only baseline factor significantly associated with a higher risk of definite graft rejection was a preoperative history of glaucoma, particularly when previous glaucoma surgery had been performed and glaucoma medications were being used at the time of transplant (10-year incidence 35% ± 23% compared with 14% ± 4% in eyes with no history of glaucoma/intraocular pressure treatment, P = 0.008).
CONCLUSIONS: Patients who experienced a definite rejection event frequently developed graft failure raising important questions as to how we might change acute and long-term corneal graft management. Multivariate analysis indicated that previous use of glaucoma medications and glaucoma filtering surgery was a significant risk factor related to a definite rejection event.

Entities:  

Mesh:

Year:  2014        PMID: 25119961      PMCID: PMC4653080          DOI: 10.1097/ICO.0000000000000212

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  35 in total

1.  Postoperative risk factors influencing corneal graft survival in the Singapore Corneal Transplant Study.

Authors:  Arundhati Anshu; Laurence S Lim; Hla Myint Htoon; Donald T H Tan
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

2.  Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.

Authors:  L Malvitte; T Montange; A Vejux; C Baudouin; A M Bron; C Creuzot-Garcher; G Lizard
Journal:  Br J Ophthalmol       Date:  2006-08-30       Impact factor: 4.638

3.  The effect of ABO blood incompatibility on corneal transplant failure in conditions with low-risk of graft rejection.

Authors:  Steven P Dunn; Walter J Stark; R Doyle Stulting; Jonathan H Lass; Alan Sugar; Mark A Pavilack; Patricia W Smith; Jean Paul Tanner; Mariya Dontchev; Robin L Gal; Roy W Beck; Craig Kollman; Mark J Mannis; Edward J Holland
Journal:  Am J Ophthalmol       Date:  2008-12-04       Impact factor: 5.258

4.  How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis.

Authors:  Keryn A Williams; Adrian J Esterman; Christine Bartlett; Helene Holland; Ngaere B Hornsby; Douglas J Coster
Journal:  Transplantation       Date:  2006-03-27       Impact factor: 4.939

5.  Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty.

Authors:  Sanjay V Patel; David O Hodge; William M Bourne
Journal:  Am J Ophthalmol       Date:  2005-02       Impact factor: 5.258

6.  Effect of glaucoma on corneal graft survival according to indication for penetrating keratoplasty.

Authors:  Rosalind M K Stewart; Mark N A Jones; Mark Batterbury; Derek Tole; Daniel F P Larkin; Stephen B Kaye
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

7.  Baseline donor characteristics in the Cornea Donor Study.

Authors:  Alan Sugar; Robin L Gal; roy W Beck; Katrina J Ruedy; Christopher L Blanton; Robert S Feder; David R Hardten; Edward J Holland; Jonathan H Lass; Mark J Mannis; Michael B O'Keefe
Journal:  Cornea       Date:  2005-05       Impact factor: 2.651

8.  Specular microscopy ancillary study methods for donor endothelial cell density determination of Cornea Donor Study images.

Authors:  Beth Ann Benetz; Robin L Gal; Katrina J Ruedy; Carmella Rice; Roy W Beck; Andrea D Kalajian; Jonathan H Lass
Journal:  Curr Eye Res       Date:  2006-04       Impact factor: 2.424

9.  Recipient risk factors for graft failure in the cornea donor study.

Authors:  Alan Sugar; Jean Paul Tanner; Mariya Dontchev; Brad Tennant; Robert L Schultze; Steven P Dunn; Thomas D Lindquist; Robin L Gal; Roy W Beck; Craig Kollman; Mark J Mannis; Edward J Holland
Journal:  Ophthalmology       Date:  2009-04-23       Impact factor: 12.079

10.  Risk factors for human corneal graft failure within the Australian corneal graft registry.

Authors:  Keryn A Williams; Marie Lowe; Christine Bartlett; Thu-Lan Kelly; Douglas J Coster
Journal:  Transplantation       Date:  2008-12-27       Impact factor: 4.939

View more
  14 in total

1.  Update on the Management of High-Risk Penetrating Keratoplasty.

Authors:  Sayena Jabbehdari; Alireza Baradaran Rafii; Ghasem Yazdanpanah; Pedram Hamrah; Edward J Holland; Ali R Djalilian
Journal:  Curr Ophthalmol Rep       Date:  2017-02-02

2.  Comparison of outcomes and complications of deep anterior lamellar keratoplasty and penetrating keratoplasty performed in a large group of patients with keratoconus.

Authors:  Ashbala Khattak; Fouad R Nakhli; Khaled M Al-Arfaj; Abdullah A Cheema
Journal:  Int Ophthalmol       Date:  2017-05-22       Impact factor: 2.031

3.  [Corneal graft failure?]

Authors:  V Duisdieker; K U Loeffler; F G Holz; M C Herwig
Journal:  Ophthalmologe       Date:  2016-11       Impact factor: 1.059

4.  Evolving Techniques in Corneal Transplantation.

Authors:  Grace E Boynton; Maria A Woodward
Journal:  Curr Surg Rep       Date:  2015-02-01

5.  Indications and graft survival analysis in optical penetrating keratoplasty in a tertiary care center in North India: a 5-year study.

Authors:  Sudesh Kumar Arya; Amit Raj; Ravi Kant Bamotra; Anubha Bhatti; Jyoti Deswal; Meenakshi Sindhu
Journal:  Int Ophthalmol       Date:  2017-07-07       Impact factor: 2.031

6.  Optical coherence tomography refraction and optical path length correction for image-guided corneal surgery.

Authors:  Yuan Tian; Mark Draelos; Ryan P McNabb; Kris Hauser; Anthony N Kuo; Joseph A Izatt
Journal:  Biomed Opt Express       Date:  2022-08-31       Impact factor: 3.562

7.  Optical Coherence Tomography-Guided Robotic Ophthalmic Microsurgery via Reinforcement Learning from Demonstration.

Authors:  Brenton Keller; Mark Draelos; Kevin Zhou; Ruobing Qian; Anthony Kuo; George Konidaris; Kris Hauser; Joseph Izatt
Journal:  IEEE Trans Robot       Date:  2020-04-16       Impact factor: 6.835

8.  Outcomes of Penetrating Keratoplasty After Open Globe Injury.

Authors:  Katie X Li; Asad F Durrani; Yunshu Zhou; Peter Y Zhao; Bradford L Tannen; Shahzad I Mian; David C Musch; David N Zacks
Journal:  Cornea       Date:  2021-11-10       Impact factor: 3.152

9.  Optical Coherence Tomography Guided Robotic Needle Insertion for Deep Anterior Lamellar Keratoplasty.

Authors:  Mark Draelos; Gao Tang; Brenton Keller; Anthony Kuo; Kris Hauser; Joseph A Izatt
Journal:  IEEE Trans Biomed Eng       Date:  2019-11-20       Impact factor: 4.538

10.  Factors Associated With Graft Rejection in the Cornea Preservation Time Study.

Authors:  R Doyle Stulting; Jonathan H Lass; Mark A Terry; Beth Ann Benetz; Nathan J Cohen; Allison R Ayala; Maureen G Maguire; Christopher Croasdale; Yassine J Daoud; Steven P Dunn; Kenneth M Goins; Pankaj C Gupta; Marian S Macsai; Shahzad I Mian; Sudeep Pramanik; Jennifer Rose-Nussbaumer; Jonathan C Song; Walter J Stark; Alan Sugar; David D Verdier; Loretta B Szczotka-Flynn
Journal:  Am J Ophthalmol       Date:  2018-10-09       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.